Journal of Clinical Nuclear Medicine Publishes Results of Tiziana’s Nasal Foralumab in Study Treating Moderate Alzheimer's DiseaseNEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd.

阿尔茨海默病（Alzheimer’s disease, AD）作为老年人群中最常见的神经退行性疾病，其特征性病理包括 β- 淀粉样蛋白（Aβ）斑块沉积、神经原纤维缠结以及进行性认知功能衰退。尽管流行病学研究早已指出高脂饮食（High-Fat Diet, HFD）诱导的肥胖是 AD 的风险因素，但其中的分子机制一直未被充分阐明。小胶质细胞作为大脑的固有免疫细胞，在 AD ...

Sex-based differences in microglia could help explain patterns in brain diseases. For example, Alzheimer’s affects more women ...

CAR-T cell therapy, a revolutionary cancer treatment, is now under scrutiny due to potential cognitive complications like ...

Explore why INmune Bio, Inc. is a speculative Strong Buy for high-risk investors. Click for the upcoming catalysts that make ...

Studies suggesting that certain viral infections may influence the onset of Alzheimer's disease are gaining attention. In ...